Health Care & Life Sciences » Biotechnology | Epigenomics AG

Epigenomics AG | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,588.00
1,507.00
2,082.00
4,201.00
1,864.00
1,533
Cost of Goods Sold (COGS) incl. D&A
1,283.00
1,498.00
1,840.00
1,987.00
580.00
748
Gross Income
305.00
9.00
242.00
2,214.00
1,284.00
785
SG&A Expense
8,140.00
8,868.00
10,249.00
15,239.00
11,821.00
14,755
EBIT
7,817.00
8,600.00
9,424.00
12,648.00
9,956.00
13,406
Unusual Expense
187.00
37.00
-
-
-
-
Non Operating Income/Expense
364.00
254.00
160.00
336.00
336.00
509
Interest Expense
33.00
517.00
3.00
1.00
175.00
550
Pretax Income
7,277.00
8,881.00
9,249.00
12,296.00
10,449.00
13,430
Income Tax
134.00
27.00
264.00
1,135.00
214.00
738
Consolidated Net Income
7,411.00
8,854.00
8,985.00
11,161.00
10,235.00
12,692
Net Income
7,411.00
8,854.00
8,985.00
11,161.00
10,235.00
12,692
Net Income After Extraordinaries
7,411.00
8,854.00
8,985.00
11,161.00
10,235.00
12,692
Net Income Available to Common
7,411.00
8,854.00
8,985.00
11,161.00
10,235.00
12,692
EPS (Basic)
0.62
0.65
0.52
0.55
0.44
0.47
Basic Shares Outstanding
11,940.80
13,666.50
17,117.10
20,271.80
23,161.60
27,016.20
EPS (Diluted)
0.62
0.65
0.52
0.55
0.44
0.47
Diluted Shares Outstanding
11,940.80
13,666.50
17,117.10
20,271.80
23,161.60
27,016.20
EBITDA
7,018.00
7,830.00
8,756.00
12,292.00
9,613.00
13,098
Other Operating Expense
18.00
259.00
583.00
377.00
581.00
564
Non-Operating Interest Income
22.00
19.00
18.00
17.00
18.00
17

About Epigenomics

View Profile
Address
Geneststraße 5
Berlin Berlin 10829
Germany
Employees -
Website http://www.epigenomics.de
Updated 07/08/2019
Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. It offers Epi proColon, a blood-based test for the early detection of colorectal cancer; Epi proLung, a confirmatory test that aids in the diagnosis of lung cancer, and Epi BiSKit, a kit for the preparation of purified, bisulfite-converted DNA. The comapny was founded by Oliver Schacht, Christian Piepenbrock, Kurt Berlin, Jörn Walter, and Ivo Gut on April 30, 1997 and is headquartered in Berlin, Germany.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.